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ABSTRACT
THE ROLE OF THE CYSTEINE/GLUTATHIONE REGULATORY GENES CDO1,
GSH1, AND GSH2 IN YEAST-MOLD DIMORPHISM OF THE
PATHOGENIC FUNGUS HISTOPLASMA CAPSULATUM
by Melissa Anne Adams
December 2012
The dimorphism of Histoplasma capsulatum (Hc) from a mold to yeast is
regulated by many environmental factors such as temperature and thiol concentrations.
Histoplasma exists in the soil (or in vitro at 25ºC) as a multicellular saprophytic mold. In
the lungs of an infected host (or in vitro at 37ºC), a shift to the unicellular parasitic yeast
occurs. Sulfhydryl groups (-SH), especially cysteine, are necessary in the culture medium
for the mold to yeast transition. Cysteine is the precursor for the synthesis of glutathione.
Enzymes involved in the cysteine metabolism pathway are being studied in order to
evaluate their role in the dimorphism.
Cysteine dioxygenase (CDO1), is a cytosolic enzyme that oxidizes cysteine to
cysteine sulfinic acid. Glutathione biosynthesis occurs through two enzymes, Gammaglutamyl cysteine synthetase (GSH1), and glutathione synthetase (GSH2). The isolation
of the cDNA of these three genes was accomplished by 5’ and 3’ RACE (rapid
amplification of cDNA ends) PCR. The expression level of each gene in both the yeast
and mold morphotypes of four Hc strains was examined by northern blotting and realtime PCR. CDO1, which was previously isolated in our lab, is expressed in both the
mold and yeast phases of the organism while GSH1 and GSH2 are expressed in only the
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yeast phase. Analysis of CDO1 indicated transcript levels and enzyme activity in both
the mold and yeast morphotypes. A western blot of CDO1 using a flag tag fusion
identified the protein size to be approximately 24 kDa. GSH1 and GSH2 mRNA levels
were increased in the yeast morphotypes. GSH1 mRNA levels were increased by 20 fold
in the 186 AS strain and 12 fold for GSH2. Northern blot and RT-PCR analyses show
GSH1 and GSH2 are weakly expressed in the mold morphotype and strongly upregulated
in the yeast morphotype.
Extensive knockout analysis of CDO1, GSH1, and GSH2 was attempted to
evaluate the loss of function on dimorphism. No viable transformants were able to be
obtained. These results indicate these genes may be essential in order for the organism to
survive in the yeast morphotype. Studies in other dimorphic organisms have had similar
results.
Because we were unable to create genetic knockouts, we examined the effects of
overexpression to attempt to gain more information regarding the function of these genes.
The hypothesis that overexpression of GSH1 or GSH2 in the yeast morphotype would
inhibit the transition to the mold morphotype at the permissive temperature (25ºC) was
therefore tested. Overexpression of GSH1 or GSH2 (driven by the strong Tef1 promoter)
resulted in yeast cells that were unable to shift to the mold morphotype at 25ºC. Northern
blot analysis of the transformants showed strong expression of GSH1 and GSH2 in the
mold morphotype. Growth analysis did not indicate any differences in the rate of growth
between the wildtype and transformants in the yeast morphotype.
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CHAPTER I
INTRODUCTION
Histoplasma capsulatum is a dimorphic pathogenic fungus that causes
histoplasmosis, a respiratory disease in man. Approximately 500,000 people are affected
by the disease each year (9). H. capsulatum exists in the soil as a saprophytic
multicellular mold and as a unicellular yeast in infected tissue. The organism grows in
the soil as mold, but when the soil is disturbed the spores are dispersed and may be
inhaled. At body temperature, or 37ºC, the mold converts to pathogenic yeast (24). The
mold to yeast conversion is required for the progression of the disease (18, 25).
Histoplasmosis is predominately found in temperate, subtropical, and tropical
zones. The disease is endemic to the United States in the Mississippi and Ohio River
Valleys (29). It is mostly confined to the lungs and often results in asymptomatic or mild
flu-like symptoms in immunocompetent individuals. The disease can be can be fatal for
immunocompromised individuals including infants, the elderly, cancer patients, HIV
patients, etc. The disease can also disseminate to other parts of the body including the
bone marrow, spleen, and liver.
The shift from mold-to-yeast can be done easily in the laboratory by changing the
incubation temperature from 25ºC to 37ºC. The interconversion between mold and yeast
allows H. capsulatum to be a model organism for reversible development in lower
eukaryotic organisms. The regulation of the mold to yeast shift is a topic of particular
interest because the mold to yeast shift is required for disease to occur. Environmental
conditions such as temperature and available nutrients play a large role in the dimorphism
(17). In the absence of required nutrients, the shift will not occur despite the temperature
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shift. In particular, sulfhydryl groups (especially cysteine) are necessary for the mold to
yeast transition (18).
In early studies, it was found that the amino acid cysteine plays a large role in the
mold to yeast shift (7). Early studies by Kumar et al., revealed that sulfur metabolism has
a critical role in the mold to yeast conversion (16, 17, 18, 19). CDO1 produces cysteine
sulfinic acid (CSA) from cysteine. CSA is a key intermediate in cysteine metabolism.
CDO1 is thought to regulate the intracellular level of free cysteine or provide a product
necessary for the transition to the yeast state. The importance of the nutrient cysteine
leads to the question of what happens to the cysteine after it enters the cell. In many
organisms such as rats, mice, humans and fungi, cysteine is known to be converted to
glutathione (GSH) via the activities of GSH1 and GSH2 (1, 3, 5, 11, 15, 20, 30, 32).
In general, changes in glutathione metabolism may lead to changes in the reduced
thiol level in cells. These reduced thiol levels may initiate morphological transitions. It
has been found in other dimorphic fungi such as Aureobasidium pullulans that there are
always higher glutathione levels in the yeast phase than in the mold (5). A shotgun
microarray by Hwang et al. (10), revealed that GSH1 is expressed 11 fold more in the
yeast phase of H. capsulatum than in the mold phase. GSH is synthesized by two ATPdependent enzymes, gamma-glutamyl cysteine synthetase (GSH1) also known as
glutamate cysteine ligase (GCL), and glutathione synthetase (GSH2). These are both
cytosolic enzymes (6, 30, 33, 34).
The cysteine pathways are a great interest in relation to the dimorphism. Kumar
et al. reported in 1983 that CDO1 activity was only present in the yeast phase of
Histoplasma capsulatum (14), however our northern blot data shows that CDO mRNA is
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present in both the mold and the yeast phases of the organism. The purpose of this study
is to further analyze the role of -SH compounds in dimorphism and reconcile the disparity
that CDO1 activity is reportedly yeast specific, but the CDO1 transcript is expressed in
both the mold and yeast morphotypes of H. capsulatum. The second major goal is to
isolate and characterize the GSH1 and GSH2 genes, and their respective enzymes, in
order to begin studies on their role in dimorphism.
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CHAPTER II
LITERATURE REVIEW
History of Histoplasma capsulatum
An autopsy case from the Panama Canal in December of 1905 was where a
pathologist by the name of Samuel Darling described Histoplasma capsulatum. His
description was of structures that were plasmodium like, inhabited in histocytes, and
encapsulated thus making the name Histoplama capsulatum. It is now known that H.
capsulatum does not have a capsule, but the name remains. In 1932, the first premortem diagnosis of histoplasmosis was from an infant’s blood smear (9).
Histoplasmosis, The Disease
The disease histoplasmosis occurs through the inhalation of mycelia fragments or
spores. Humans generally contract histoplasmosis by traveling to an endemic area were
they are exposed to contaminated soil enriched by bird or bat excrement. When the soil
is disturbed, the spores are inhaled. The mold then shifts to the yeast causing the disease.
The disease can be diagnosed by a laboratory culture or blood test. Most individuals
experience flu-like symptoms that are resolved within a few weeks. For
immunocompromised individuals, the symptoms can be much worse and can lead to
death. There are three types of histoplasmosis and they are named according to the
nature of the infection, the onset and how long the symptoms persist. The three types are
acute pulmonary histoplasmosis, chronic pulmonary histoplasmosis, and progressive
disseminated histoplasmosis (21). Treatments for histoplasmosis include antifungal
medications such as Amphotericin B which binds to sterol groups and causes
disorganization of the membrane leading to increase membrane permeability (35).
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Another therapeutic agent is Fluconazole, a member of the triazole antifungals. It works
by inhibiting the enzyme lanosterol 14-alpha demethylase, causing a decrease in
ergosterol synthesis causing malformation of fungal cell membrane (37).
Taxonomic Classification
Kingdom: Fungi
Phylum: Asocmycota
Subphylum:Ascomycotina
Class: Ascomycetes
Order: Ongenales
Family: Ongenacea
Genus: Ajellomyces (Histoplasma)
Species: capsulatum
Morphology
Mold and yeast cells have similar organelles. They both have endoplasmic
reticulum, ribosomes, elongate mitochondria, and vacuoles with lysosome like functions.
The cellular morphology of mold cells is very different from yeast cells. Yeast cells are
oval in shape, 1 to 3 micrometers in size, and have a thin cell wall (17). They grow at
37ºC and reproduction occurs through budding. Histoplasma capsulatum yeast cells are
uninucleate. Yeast cells are the only kind found in infectious tissues. Mold cells have
hyphae that are approximately 20nm thick. Mold cells have an additional organelle
called a Woronin body to regulate cytoplasmic flow. The hyphae also contain Golgi like
cisternae. The hyphae can produce two types of conidia: macroconidia and microconidia.
Microconidia are the preferential infectious form (18).
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Dimorphism
Histoplasma exists as a saprophytic multicellular mold at ambient temperatures
and grows as a unicellular yeast at body temperatures. The pathogenic state only occurs
in the yeast form. Environmental conditions such as temperature and available nutrients
play a large role in the dimorphism. In the absence of required nutrients, the shift will not
occur even at the permissive temperature. Morphological changes in the mold to yeast
shift are not evident until 18 to 24 hours after the temperature shift from 20ºC to 37ºC.
The cell begins to modify its hyphae by increasing the diameter, the outer cell wall layers
break allowing the inner cell walls to come in contact with the cytoplasm. Fragmentation
of the outer layers of the cell wall occurs. The space between the forming yeast cell and
the hyphal wall increases and the cells become rounded and separate (17).
In early studies, it was found that the amino acid cysteine plays a large role in the
mold to yeast shift. Early studies by Kumar et al. revealed in 1983 that sulfur metabolism
has a critical role in the conversion of the phases (14).

The phase transition from mold

to yeast occurs in three stages. The first stage includes approximately 40 hours of
incubation. In stage 2 (40-72 hours of incubation) cells need sulfhydryl groups, in
particular cysteine, in order to enter the third stage. After 72 hours, cells enter the third
stage of transition and CDO1 activity appears (14). CDO1 produces cysteine sulfonic
acid (CSA) from cysteine. CSA is a key intermediate in cysteine metabolism. CDO1 is
thought to regulate the intracellular level of free cysteine or provide a product necessary
for the transition to the yeast state (3, 26, 27).
Sulfhydryl blocking agents such as p-chloromeruriphenylsulfonic acid (PCMS)
can inhibit the mold to yeast transition (22). Sulfhdryl reducing agents such as
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dithiothreitol can force the cells to remain in the yeast state even at 25°C (14, 16). Other
enzymes related to cysteine metabolism and possibly dimorphism, are cystine reductase,
a yeast specific enzyme, and sulfite reductase whose activity is repressed in yeast cells (7,
16). The requirement for cysteine in the yeast may be due to the inactive sulfite
reductase gene. Sulfite reductase is needed for cysteine biosynthesis. Other genes that
are involved in sulfur metabolism are GSH1 and GSH2. It is unclear what role these
genes play in the transition from the mold to yeast morphotype. Figure 1 is a diagram of
sulfur metabolism in mammals, it is thought to be similar for Histoplasma capsulatum.

Figure 1. Cysteine metabolism in mammals. Adapted from Bella D. L. et al.
1999 American J. of Physiology (1). Cysteine metabolism is thought to be
similar in Histoplasma capsulatum.
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Virulence in Histoplama capsulatum
In order to treat histoplasmosis, it is important to understand how the organism
survives once inside the host cell. An area of interest is the yeast cell within host
macrophages, particularly after phagosome lysosome fusion. Hc has an array of
mechanisms to enhance its survival within the host. One such way is by increasing the pH
inside the phagolysosomes. Phagolysomes contain hydrolytic enzymes and lysosomal
proteases that are activated by a low pH. For the fungus to survive, it must increase the
pH within the phagolysosome. The method through which the pH is changed is unclear
(4).
Phagocytes are triggered to release toxic oxygen and nitrogen metabolites such as
super oxide, hydrogen peroxide, singlet oxygen, and hydroxyl radicals, and nitric oxide
when infection occurs. Hc increases its survival by producing catalases and oxidases to
break down these cytotoxic metabolites (2, 8, 12, 25, 35). In macrophage infection,
Histoplasma does have changes at the molecular level. For instance, the CBP-1 protein is
found only in the yeast (pathogenic) form and not in the mold (36). CBP-1 is a calcium
binding protein that allows free calcium ions in phagosomes to be taken in by the
Histoplasma cells (36). This allows the fungus to live in calcium poor conditions and
also prevents lysosomal activation due to the lack of calcium to activate them. Another
yeast specific protein includes alpha-(1,3)-glucan which acts as an autoinducer in the
quorum sensing mechanism in Histoplasma (4, 23).
Strains of Histoplasma capsulatum
Histoplasma exists as three species, Histoplasma capsulatum (Hc), Histoplasma
dubosii (Hd) and Histoplasma farcinimosa (Hf). Histoplasma dubosii (Hd) is an
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organism found in Africa. Histoplasma farcinimosa, also known as Cryptococcus
farciminosa, is an old world horse pathogen. Hc is the most common and is found in
many areas of the world. It is endemic to the United States in the Ohio and Mississippi
River Valleys. It can also be found in South America, Africa, and Australia. Hc is
composed of twenty- three strains that are divided into three classes based on restriction
fragment length polymorphisms (RFLP’s) of mitochondrial and ribosomal DNA’s (13,
31). Class 1 had contained a single strain, Downs, but a new strain,WU24 has been
isolated only from AIDS patients and has been placed in North American Class I with
Downs. Class 2 is composed of G217B and G222B both of which are found in North
America. Class 3 is made up of 6 Central American isolates, including G184AS and
G186AS. Class 2 is the most virulent and 16 strains belong to this class (17).
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CHAPTER III
MATERIALS AND METHODS
Strains and Growth Conditions
Histoplasma capsulatum strains G184AS, G186AS, 217B, and Downs (all strains
were kind gifts from Dr. Bill Goldman at the University of North Carolina except Downs
which was ATCC# 38904) were grown in two kinds of media: Glucose Yeast Extract
(GYE) and Histoplasma Macrophage Media (HMM). GYE was used to grow yeast and
mold cultures for DNA and RNA extractions. GYE was composed of 2.0 % w/v glucose
and 1.0 % w/v yeast extract. The yeast form was grown with gyratory shaking at ~150
rev/min at 37° C to mid-log phase. The mold form was grown with gyratory shaking at
100 rev/min at 25°C. After 1.5- 2 weeks, 5 ml of mold culture was inoculated into fresh
100 ml of GYE medium and incubated at 25°C for 3 days. After 3 days the culture was
harvested for either DNA or RNA extraction. The synthetic, defined HMM medium was
prepared and used as described below.
G186AS ura5- and G184AS ura5- were grown in HMM media for electroporation
purposes. HMM broth was composed of 25 ml of 2X HMM (2.14 g of F-12 powder,
3.64 g glucose, 0.2g glutamic acid, 2 ml cysteine stock, 1.2 g HEPES, pH 7.5 and filter
sterilized). 20 ml of H2 O was added to the broth. G186AS ura5- and G184 ura5- are
uracil auxotrophs and thus growth media was supplemented with 100 µg/ml of uracil.
The HMM broth also contained 50 µg/ml of ampicillin and 100 µg/ml of streptomycin to
prevent bacterial contamination during the prolonged growth periods and manipulations
needed for some experiments. Petri plates were prepared by mixing equal volumes of 2X
HMM broth and sterilized 1.5% w/v agarose. After cooling, 50 µg/ml of ampicillin, 100
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µg/ml of streptomycin, and 5 ml of 10% w/v uracil were added. Luria Broth (LB) or
plates were used for routine experiments for plasmid isolations or for transformations into
E. coli cells. The LB broth contained 0. 5 g of NaCl, 0.5 g of yeast extract, 10.0 g of
tryptone, and H2O was added for a final volume of 1.0 L. When making plates, 15.0 g/L
of Bacto agar was added to the broth and appropriate antibiotic for selection was added
after cooling.
E.coli Competent Strains
E.coli strains used for general transformations were Sure2 competent cells
(Stratagene), Max Efficiency Stable 2 competent cells (Invitrogen) and One Shot Top10
competent cells (Invitrogen). Stable II cells and Sure 2 cells were used because they give
better results with Hc telomeric repeat plasmids. Telomere plasmids prepared in other
strains occasionally allow sequence re-arrangements due to the telomeric repeats. When
using tetracycline, Sure 2 cells cannot be used due to antibiotic resistance.
Sub Cloning
DNA fragments were either sub-cloned into Topo pCR2.1 (Invitrogen) 3.9 kb, or
PGEM-T easy vector (Promega) 3 kb. The Manufacturer’s suggested protocol was
followed.
Transformation into E. coli cells
E.coli cells were transformed with 1-10 ng of plasmid DNA as follows. 3-5 µl of
DNA sample was gently mixed with 25-50 µl of competent cells and incubated on ice for
30 minutes. The cells were heat shocked at 42°C for 30 seconds and incubated on ice for
2 minutes. 250 µl -400 µl of S.O.C (2.0 g of bacto tryptone, 0.5 g of bacto yeast extract.
0.25 ml of 1M KCL, 1.0 ml 2M Mg, and 1.0 ml 1M NaCl) was added. The cell culture
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was incubated at 37°C for 1 hour and then plated on the specified agar plates. The plates
were incubated at 37°C overnight.
Transformation into Hc cells
In order to electroporate DNA into Hc cells, the DNA must be cloned into a telomeric
vector. The vector must be in a linearized form. The vector was linearized to expose the
telomeric repeats. The sequences TAACCC, and GGGTTA were used as the telomeric
repeats. These repeats enhance cloning efficiency and decreases re-arrangements of DNA
inside Hc cells. The telomeric plasmids such as pRPU1, and pRPUTI were designed to be
cut with PmeI and Pac I restriction enzymes, to remove the tetracycline marker and
expose the telomeric repeats. The DNA was separated by electrophoresis, and
Zymocleaned by Zymo Clean Gel DNA Recovery kit (Zymo Research) according to
manufactures instructions. DNA concentration was determined by UV absorbance with a
Nanodrop spectrophotometer.
Hc cells were electroporated by using the following procedure; Hc yeast cells
were grown to mid-log phase. 5.0 ml of cells were centrifuged at 300 x g for 5 minutes.
Cells were washed with 5 ml of 10% w/v mannitol and centrifuged for 5 minutes. The
pellet was resuspended in 200 µl of 10% mannitol and the solution was transferred to a
0.2 cm electroporation cuvette (Biorad). 50-100 ng of linearized plasmid was added to
the cuvette and mixed thoroughly. The cuvette was then placed into an electroporator,
Gene Pulser X cell, (Bio-Rad). The cells were electroporated at the following settings;
750 V, 71 µF, and 150 ohms (resulting in an exponential pulse width and duration of 10.6
ms, and plated on HMM plates without uracil. The plates were placed in an incubation
chamber and incubated at 37 °C.
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RNA Extraction
Yeast cells, were grown to mid-log phase. Mid-log phase was reached at
suspension Klett Summerson calorimeter reading of approximately 200 (600 nm filter).
10 ml of yeast cells were centrifuged for 5 minutes at 3000 x g. Cells were washed with 5
ml of cold water, and resuspended in 1.0 ml of cold water and transferred to a fresh 1.5
ml micro centrifuge tube. For mold cultures, 10 ml of mold cells and 10 ml of cold water
was filtered through a vacuum onto a 25 mm 0.45µM Millipore filter. The mold was
scraped off of the filter paper with a sterile soft plastic spatula and was placed in a 1.5 ml
micro centrifuge tube. To the tube, 300 µl of 0.5 mm glass beads, 400 µl of P:C (pH= 4.5
phenol:chloroform 5:1) and 400 µl of Extraction buffer (0.1M Na acetate 0.2 M NaCl,
pH 5, 0.2% SDS) was added. The sample was vortexed for 10 minutes on maximum
speed on a “Vortex Genie” and centrifuged for 5 minutes on maximum speed to spin
down debris. The supernatant was transferred to a fresh 1.7 ml micro centrifuge tube
containing 1ml of cold ethanol. The sample was centrifuged for 5 minutes on maximum
speed. All liquid was removed by pipetting off the liquid phase and the pellet was
dissolved with 50 µl of TE containing 2% SDS.
DNA Extraction
DNA was extracted from mid-log phase yeast cells as follows: 0.5 ml of yeast
cells were centrifuged at 2000 x g for 5 minutes. Cells were washed in 35 ml of cold
water and centrifuged at 2000 x g again. The pellet was resuspended in 6.0 ml of DNA
extraction buffer (100 mM Tris pH 8.0, 10mM EDTA, 250 mM NaCl), 6.0 ml of phenol:
chloroform (5:1) and 800 µl of 0.45 mM glass beads. The samples were vortexed on max
speed on a “Vortex Genie” for 1 minute and then incubated on ice for 1 minute. The
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vortex and ice incubation procedure was repeated for a total of 5 minutes vortex time.
The samples were centrifuged at 10,000 x g for 10 minutes. The supernatant was
transferred to clean tube and 30 µl of 5 mg/ml of Rnase A was added to the samples. The
samples were next incubated at 37°C for 1 hour and then extracted with equal volumes of
phenol: chloroform 5:1. The samples were centrifuged at 10,000 x g for 10 minutes at
4°C. The supernatant was transferred to a fresh tube and 2 volumes of ethanol were added
to the tube. Next, the samples were centrifuged again at 10,000 x g for 10 min at 4°C.
The pellets were air–dried briefly and dissolved with water or TE.
Plasmid Isolation and DNA Purification
Plasmid isolation was conducted by Zippy Plasmid Miniprep I kit (Zymo
Research). DNA was purified by Zymo Clean Gel DNA Recovery kit (Zymo Research).
Manufacturer’s instructions were followed.
Nucleic Acid Quantification
All nucleic acid quantification was conducted by UV absorbance with a
Nanodrop ND-1000 Spectrophotometer. Manufacturer’s instructions were followed.
Restriction Digests
All restriction digests were conducted by using NEB buffers and enzymes from
NEB Biolabs. Manufacturer’s instructions were followed.
Polymerase Chain Reaction (Standard PCR)
The standard PCRs were set up with a volume of 25 or 50 µl. The following
components and concentrations were in each PCR unless otherwise specified:1-10 ng of
DNA template, 1X PCR buffer, 0.2mM dNTPs, 0.2µM Forward primer, 0.2µM Reverse
primer, polymerase with a stock concentration of 50X and the mixture was finished with
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H2O for a final volume of 25-50 µl. The cycling parameters used were as follows: 95°C
for 10 seconds for denaturing, 55-68°C for 30 seconds for annealing of primers, and 6872°C for 1minute/kilobase of DNA fragment for elongation. The cycles were repeated 30
times unless otherwise indicated.
Polymerase Chain Reaction (Modified for fusion PCR)
To fuse two or more DNA fragments together, each desired fragment for the
fusion was first amplified separately by standard PCR procedure described earlier. For
fusion PCR the standard PCR procedure was modified as follows. Primers were
excluded from the first reaction of fusion PCR. The denaturing step was set at 95°C for
20 seconds. A temperature gradient was set for the annealing temperature for 2 minutes.
The elongation step was set at 68 °C for 1 minute/kilobase. The cycles were repeated 1012 times. The elongation step was extended for an additional ten minutes after the
completion of cycles 10 or 12. After completion of amplification, ~0.5-1 µl of the PCR
was used as a template for the next PCR, and nested primers were added to the PCR
mixture. This PCR was conducted by standard procedures as described earlier with the
addition of a temperature gradient for the annealing temperature. The product was then
analyzed by electrophoresis on a 0.7% agarose gel. The primers generated for fusion of
DNA fragments consisted of a standard forward and reverse primer, nested forward and
reverse primers, and primers linking the two fragments together by adding approximately
20 additional nucleotides homologous to the adjacent fragment to the previous fragment.
Electrophoresis
The apparatus used for gel electrophoresis was the Gel XL Ultra (Labnet) Model
EO145. 0.7% agarose gels consisted of 0.1 µg/ml ethidium bromide and 1X Tris acetate
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buffer pH 7.6 A 20X stock of Tris acetate buffer (48.8g/L Tris base, 11.4 ml/ L glacial
acetic acid, 20 ml/L 0.5 M Na EDTA) was diluted to 1X for each gel. Electrophoresis
was conducted at 100 volts until the bromophenol blue tracking dye reached the desired
distance from the wells. The gel was removed from the apparatus and pictures were taken
by using Kodak EDAS 290.
Sequencing
A cDNA library was made and then RACE PCR was performed. The products
were observed on a 0.7% agarose gel, extracted, and purified by Zymoclean Gel DNA
Recovery kit (Zymo Research). The PCR products were sub-cloned into the PCR2.1
TOPO cloning system by Invitrogen and transformed into Sure2 cells (Stratagene). The
cells were plated on LB plates supplemented with 50 µg/ml of ampicillin and incubated
at 37°C for overnight. The following day several colonies were observed and a few were
selected and inoculated into 5ml of LB broth supplemented with 5 µg/ml of ampicillin.
These were placed in a rotating drum in an incubator at 37°C overnight. The following
day plasmid isolation was conducted on the grown cultures by using the Zyppy plasmid
miniprep kit (Zymo). The plasmid isolations were sequenced by the University of Maine
DNA sequencing facility. Primers from pCR2.1 M13 F and M13 R were used to
generate a starting point for primer walking in order to obtain the proper sequence of
GSH1 and GSH2. The sequences were assembled and then aligned by using the computer
software program MacVector 8.0. MacVector 8.0 was also used to translate and align the
cDNA to the genomic DNA in order to find introns.
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Radiolabeling DNA Probes
Purified DNA fragments were labeled with 32P dATP using DECA primer II kit
(Ambion). Manufacturer’s instructions were followed.
Northern Blot Analysis of CDO1, GSH1, and GSH2
Approximately 10 µg of total RNA of mold and yeast from each strain were
loaded on a denaturing 1.2% agarose gel containing 1X MOPS buffer (Amresco). The
samples were prepared by adding 1% of 10X MOPS, 6.5% of formaldehyde, 50%
deionized formamide, and 1µl of 1mg/ml ethidium bromide. The samples were heated at
55°C for 15 minutes and placed on ice for 5 minutes. 1/5 volume of loading buffer was
added to the sample. The gel was run in 1X MOPS buffer at 5 v/cm. The RNA was
transferred onto a Hybond N nylon membrane (Amersham) with 20X SSC by using a
turbo blotter (Schleincher and Schuell). The apparatus was set up according to the
manufacturer’s instructions. After 2 hours, the RNA was cross linked to the membrane by
soaking the membrane with 2X SSC and exposing the membrane to 254 nm UV light for
a total exposure of 120,000 mJ/cm2. The membrane was pre-hybridized in an equal
volume of 1M Na2HPO4 and 1M NaH2PO4, 20% w/v SDS and 5 ml of H2O. A denatured
radiolabeled probe of CDO1, GSH1, or GSH2 made from genomic DNA (gDNA) by
PCR was added to the pre-hybridization solution and was hybridized at 65° C overnight.
The following day the membrane was washed once with 2X SSC and 1% (w/v) SDS for
15 minutes, and twice with 0.1% SSC and 0.1% w/v SDS for 15 minutes. The blots were
wrapped in saran wrap and stored in the refrigerator for further use.
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Southern Blots
DNA was electrophoresed on an agarose gel and transferred onto a nylon membrane
with 0.4M NaOH. The membranes were neutralized by washing in 2X SSC three times
for 5 minutes each. The membrane was air dried and stored at room temperature for
future use.
ReProbing Blots
Blots were stripped by adding boiling 0.1% w/v SDS to the blot, approximately 23 times, and then reprobing by adding 18s rDNA (control) probe to fresh prehybridization solution. Hybridization proceeded as mentioned previously.
Autoradiography
The Northern blots and Southern blots were analyzed by using a Typhoon 9400
Imager (Molecular Dynamics; part of Amersham Pharmacia Biotech). When using the
Typhoon Imager manufacturer’s instructions were followed.
cDNA Preparation
Total RNA of Hc 186AS yeast cells was treated with RQ1 RNase free DNase
(Promega) to degrade contaminating gDNA. Poly (A+) RNA was isolated by poly A
spin mRNA isolation Kit (New England Bio Labs). The Marathon cDNA amplification
kit (Clonetech) was used to construct a cDNA according to manufacturer’s protocol. A
cDNA synthesis primer which binds to the polyA tail of the RNA template was used in
the first strand cDNA synthesis. After a hybrid of RNA/cDNA was formed, the second
strand cDNA synthesis was created by using the single stranded DNA as a template.
Adaptors were ligated to the 5’ and 3’ ends of the double strand cDNA.
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Rapid Amplification of cDNA Ends (RACE) PCR
The GSH1 and GSH2 gene sequences from Aspergillus fumigatus Af 293 NCBI
accession number XP_753972.1 and Arabidopsis thaliana NM_001203879.1 were used
in a Blast search of the 186AS genome database (Washington University Genome
Sequencing center), in order to identify contigs that contained the putative GSH1 and
GSH2 genes. Gene specific primers were then made to perform a RACE PCR. The
template in the RACE PCR was the Hc 186AS yeast cDNA library. 5’ and 3’ RACE
PCR was performed separately in order to obtain a complete overlapping sequence.
CDO Assay
Enzyme was extracted from Hc cells via a modification of the method of Kumar
et al. (14). Three to five day old mold cultures of four strains (186, 217, Downs, and
184) of Histoplasma were used. The mold cells were filtered on Whatman #1 paper,
washed with cold water and resuspended in buffer A (20 mM NaPO4 made by mixing
equal volumes of equimolar Na2HPO4 and NaH2PO4 and then adding 0.2 mg/ml PMSF
from a stock solution). The yeast cells of the same four strains were grown to mid-log
phase. Ten ml of yeast cells were centrifuged at 3000 x g. The pellet was then washed
with cold water and resuspended in buffer A. The mold and yeast cells were treated the
same from this point and everything was done at 4ºC. Twice the cell pellet weight of
glass beads (0.5mm) was added to the cells, vortexed for 1 minute at maximum speed on
a “Vortex genie” and cooled for one minute, for three cycles. The cells were centrifuged
at 10,000 x g for 10 minutes. The supernatant was then moved to a new microfuge tube.
The glass beads were washed with cold water and pooled with the supernatant. The
supernatant was centrifuged at 100,000 x g for 60 minutes in a Sorvall-rc 28s centrifuge.
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A Bradford assay was then done on the supernatant according to Bio-rad protein assay
instructions. Activity was then measured by the following assay that is based on our
modification of the method of Stipanik et al. (27). Assay buffer (5mM cysteine-HCl ,
2mM NAD, 5mM Hydroxylamine HCl, and 0.25 mM (NH4)2Fe(SO4)2 made in 100mM
PO4 buffer) was prepared fresh for each assay. A standard curve of CSA was made from
5mM to 0.005mM. The standard curve was treated the same as the samples. 100µl of
assay buffer was added to 100 µl of the enzyme solution and incubated for 30 minutes at
37ºC. An equal volume of 10% (w/v) TCA was added to stop the reaction. The control
reaction was the same as the above sample, but the enzyme was not added until after the
TCA was added. The solution was centrifuged at 10,000 x g for 5 minutes to precipitate
protein. 200µl of the supernatant was placed on a (approximately 0.3 ml bed volume)
Dowex minicolumn and eluted with water. CSA production was measured by the
ninhydrin reaction. 100 µl of the eluate was added to 50µl of Sigma ninhydrin reagent.
The mixture was then incubated at 90ºC for ten minutes. After cooling to room
temperature, 150µl of 95% ethanol was added and mixed. The reaction was read on
microtiter plate reader at 550 nm.
Real Time Quantitative RT-PCR
Primer pairs for CDO1, GSH1, and GSH2 were validated by efficiency (~95% –
103%) and linearity (R2 > .98) and threshold cycle (Ct) between 20~30. The primer pairs
used are as follows:
For CDO primer pair: CDO 577 [GGGCTTGCATAAAATCTCCA]
CDO 688 [CCGTCTTCTCGTCAAAGAGG]
R2 =.997, Efficiency = 93%
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For GSH1 primer pair: GSH1 F3RT [GGCAACACATCCGCTTCAAAC]
GSH1 RTR1 [TGGGATGGGGATGTAGAGATTTAG]
R2 =.997, Efficiency = 95%
For GSH2 primer pair: GSH2 RTF8 [ACATTGTTGCCACCTCCCTCAC]
GSH2 RTB11 [AAATGCCCTTCAGTCCTCAGCC]
R2 =.997, Efficiency = 90%
Total RNA samples were extracted from mold and yeast forms of four Hc strains
(184AS, 186AS, 217B, and Downs). After extraction, treatment with RQ1 RNase-free
DNase (Promega) at 37ºC for 30 minutes was done in order to eliminate genomic DNA
contamination. The treated RNA was then extracted using phenol:chloroform (5:1)
pH=4.5. The RNA was precipitated by using one tenth of the volume of 3M sodium
acetate plus two volumes of EtOH.
The RNA was pelleted by centrifugation at 10,000 x g for 15 minutes. The pellet
was then dissolved in TE buffer (10mM Tris, 1mM EDTA). A cDNA library was then
made by using the RETROscript kit (Ambion) according to the manufacturer's
instructions. 18S primer pairs and competimer mix (2:8) from Quantum RNA 18s
Internal standards were used for internal control reactions. No-template control and noreverse transcriptase controls were also used. A 20ul reaction contained 10 µl of Full
Velocity Sybr Green QPCR mix (Stratagene), 0.2 µl of cDNA, 0.3 µl of 1:500 diluted
ROX reference dye (Strategene), and a final primer concentration of 50nM of each
primer. Reverse transcriptase was added to a standard reaction (+RT) and minus RT
reactions had no reverse transcriptase. Both the mold and yeast morphotypes were tested.
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Every round of RT-QPCR had no-template controls. Each of the reactions was done in
triplicate on the Mx3000p real time thermocycler (Stratagene).
The cycling was as shown in Table 1.
Table 1
Cycling of RT-PCR

Cycle 1

95ºC 10 min

1 cycle

95ºC 20 sec

40 cycles

60ºC 30 sec
72ºC 30 sec
Cycle 2

95ºC 1 min

1cycle

55ºC 30 sec
95ºC 30 sec

All real time quantitative PCR was analyzed with the Mx3000p Real Time PCR
analysis software.
Protein Assay
The Bradford Assay was done using the Bio-Rad Protein dye reagent according to
the manufacturer’s instructions. Bovine serum albumin was used as a standard.
Cysteine Assays
Three to five day old mold cultures were filtered on Whatman #1 paper, washed
with cold water and resuspended in Dulbecco’s Phosphate buffer saline (PBS). The yeast
cells were grown to mid-log phase which correlated to a reading of 250 as measured by a
Klett Summerson colorimeter with a 600nM filter. 30 ml of yeast cells were centrifuged
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in a 15ml Falcon tube. The pellet was washed with cold water and resuspended in 10% 5sulfosalicylic acid dehydrate (SSA). Both the mold and yeast cells had the following
protocol at 4ºC. Twice the cell pellet weight of glass beads (0.5mm) was added to the
cells, vortexed for 1 minute and cooled for one minute for three cycles. The cells were
then centrifuged at 10,000 x g for 10 minutes. The supernatant was moved to a new 2ml
microfuge tube. The protein pellet was saved for protein quantification. Protein values
obtained from the pellets were used to normalize the cysteine data. Cysteine levels were
then measured as described by the method of Dominy et al. (3).
Thin Layer Chromatography
For identification of CSA, thin layer chromatography was performed on PEIcellulose plates (Sigma). Ascending chromatography was done by using butanol-acetic
acid-water (12:3:5) as the solvent. A standard of 10mM to 10nM of cysteine and CSA
was spotted along with samples. After approximately 30 minutes of solvent flow, the
chromatogram was developed by spraying with Ninhydrin Spray (Sigma) according to
the manufacturer's directions.
Construction of Knockout Vectors
CDO1 Knockout Vector
In order to make the CDO knockout vector, 2kb upstream and 2kb downstream of
the CDO1 open reading frame was amplified by PCR using the primers CDO k/o F and
CDO k/o R. The resulting ~6kb PCR product was cloned into PCR 2.1 Topo. The
vector was then cut with ZraI and HpaI to remove 620 bases which is approximately half
of the open reading frame. In its place, a hygromycin resistance marker was added. The
vector was then cut with NaeI. The resulting product was ligated to a sequence that
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contained a uracil marker along with a tetracycline marker that had telomeric sequences
on each side. The markers were obtained from a PVUII cut of pRPUI. The resulting
vector was cut with PmeI to remove the tetracycline marker and to reveal the telomeres.
The final product was then electroporated into Histoplasma capsulatum 186AS URAcells.
GSH1 Knockout Vector
In order to make the GSH1 knockout vector, 2kb upstream and 2kb downstream
of the GSH1 open reading frame was amplified by PCR using the primers GSH1 k/o F4
and GSH1 k/o R1. The resulting ~6kb PCR product was cloned into pGem-T easy
(Promega). The vector was then cut with PmeI and ScaI to remove 732 bases which is
approximately 1/3 of the open reading frame. In its place, a hygromycin resistance
marker was added. The vector was then cut with HpaI. The resulting product was ligated
to a sequence that contained a uracil marker and a tetracycline marker with telomeric
sequences on each side. The markers were obtained from a PVUII cut of pRPUI. The
resulting vector was cut with PmeI to remove the tetracycline marker and reveal the
telomeres. The final product was then electroporated into Histoplasma capsulatum
186AS URA- cells.
GSH2 Knockout Vector
In order to make the GSH2 knockout vector, 2kb upstream and 2kb downstream
of the GSH2 open reading frame was amplified by PCR using the primers GSH2 k/o F7
and GSH2 k/o R6. The resulting ~6kb PCR product was cloned into PCR2.1 TOPO.
The vector was then cut with NdeI and NheI, to remove 650 bases which is
approximately 1/3 of the open reading frame. The vector was blunt cloned to a
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hygromycin resistance marker previously digested with EcoRV. The hygromycin marker
was obtained by PCR from the vector pGX2. The resulting vector was then cut with
ApaI. The resulting product was ligated to a sequence that contained a uracil marker
along with a tetracycline marker that had telomeric sequences on each side. The markers
were obtained from a PVUII cut of pRPUI. The resulting vector was cut with PmeI to
remove the tetracycline marker and reveal the telomeres. The final product was
electroporated into Histoplasma capsulatum 186AS URA- cells.
Knock Out Selection Process
Two sequential selection processes were used. In the first selection the construct
was used to transform a uracil auxotroph of 186AS (28, 29). The 186AS URA- strain has a
nonfunctioning Ura5 gene. The Ura5 gene was used for selection of tranformants. This
step selected for transformed cells that have the stable linearized plasmid. Ura5transformants are grown on HMM plates without uracil. The plates were incubated at
37°C. Colonies grown on the plates were inoculated into HMM broth without uracil. The
cultures grew for an incubation period of 3 weeks to allow time for double cross over
events to occur.
The second selection used was positive-negative selection. Hygromycin B and 5fluoro-orotic acid. (5-FOA) were used to select the appropriate colonies. 5-FOA selects
against the growth of uracil prototrophs. Hygromycin B is selected for by using plates
that contain hygromycin, and the Ura5 marker is selected against because the free
plasmid is disfavored allowing only those cells to survive that had a double crossover
event integrating the knock out DNA fragment into the genome. Clones were plated on
solid medium containing hygromycin B and 5-FOA. After several days, clones grown on
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the plates were inoculated into broth containing hygromycin B and 5-FOA and incubated
for 2 weeks. DNA was extracted from each clone and used as a template for southern
blot analysis and PCR to see if the double crossover event had occurred leaving a
knockout.
Flag-Tagging CDO1 by Fusion PCR
Fusion PCR was used to modify the 5’ and 3’ ends of the CDO1 gene coding
sequence. Oligonucleotide primers were used to attach a FLAG TAG epitope to the N
terminus and C terminus ends of the native CDO1 gene loci. FlagF and CDO1 R were
used to make the N terminus fusion while CDO1F and FlagR were used to make the C
terminus fusions. As shown below in Figure 2.
A.

B.
Native Nter CDO1
TTCCAACACAATGCCATATCTCGAGAACAGCGAGT
Native Cter CDO1
CAGGAAAGGGCACAAACTATGATTTTAGCATTTGTG
Flag Tag Nter
TTCCAACACAATGGACTACAAGGACGACGATGCCAT
Flag Tag Cter
AAACTAGACTACAAGGACGACGATGACAAATGATTTT
Figure 2. Strategy to introduce the FLAG TAG peptide sequence for Western
Blotting for size conformation of the CDO1 protein product. A. Schematic of the
N terminus and C terminus fusion. B. Sequence confirmation of FLAG TAG
fusions in both the C terminus and N terminus fusions after placement in pGEMTeasy.
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Western Blot
Fusion PCR was used to attach the FLAG-TAG to the C-terminus and the Nterminus of CDO1. The construct was sequenced to confirm proper placement of the
FLAG-TAG.. The product was cloned in the vector, pRPUI which has the Ura gene.
The 186AS Ura- Hc cells were electroporated with the plasmid. pRPUI without the CDO
FLAG-TAG fusion was used as a negative control. The protein was extracted from mid
log yeast and 3 day old mold from 186AS and Downs strains of Hc. Hc cells were
centrifuged in a 15 ml falcon tube at 4°C for 5 min. The cells were washed in ice cold
Dulbecco’s PBS three times. Then equal volumes of PBS and glass beads were added.
The cells were then vortexed on max speed on the “vortex genie” for three cycles with 1
minute intervals of cooling over ice. The cells were then centrifuged at 10,000xg for 15
minutes. The protein extract was resuspended in 0.125M Tris-HCl buffer (pH 6.8)
containing 2% SDS, 10% glycerol, 5% 2-mercaptoethanol, and 0.025% bromophenol
blue. The proteins were electrophoresed through a 15% polyacrylamide gel and then
blotted onto nitrocellulose membrane. The transfer buffer was 25mM Tris HCl, 192mM
glycine, and methanol (20% v/v, pH 8.3). Free binding sites of the membrane were
blocked with the incubation of 5% nonfat milk in phosphate buffered saline (PBS), 0.3%
Tween 20 (pH=7.5). The membrane was then probed with an alkaline phosphatase
linked Anti-FLAG antibody (Sigma) according to the manufacturer's directions. The
presence of the alkaline phosphatase was detected by SuperSignal West Pico
chemiluminescent Substrate (Pierce)
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CHAPTER IV
RESULTS
Sequence Analysis of GSH1
The full length cDNA of GSH1 was 2037 bp. Comparison of cDNA to
genomic DNA revealed 6 introns for the GSH1 gene as shown in Figure 3. The
open reading frame can be translated into the putative GSH1 protein with 679
amino acids as shown in Figure 4. A domain search on the NCBI website
assigned the sequence to the glutamate cysteine synthetase superfamily as shown
in Figure 5. Multiple sequence alignments with other dimorphic fungi such as
Paracoccidioides brasiliensis, and Aspergillus oryzae show high percentage of
homology between the fungi as shown in Figure 6. When compared to Homo
sapiens, the GSH1 sequence for Histoplasma capsulatum also had similarities
(Figure 6).
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68
136
204
272
340
408
476
544
612
680
748
816
884
948
1016
1084
1152
1220
1288
1356
1424
1492
1560
1628
1696
1764
1832
1900
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2172
2240
2308
2376
2444
2512
2580
2648
2716
2784
2852
2920
2988
3056
3124
3192

TTTAGCCTCCTGAAAACAACGTGCCCTATGGTTTTACGTATGGAATGATTTCGTTTCGCGTGA
AGAATAATGCGGAAGACCCAATCCCCTCTTCATGCCACTGGAGCTAAACCTGGCCTAGCGGTT
ACGACGAAAAAGCCCTAGGTTATAATTTACCAGCGTTAAGGATCGTTTATATACGGCCCAGGC
ATGGGAGCAGTCCATGGATATATATTGCTTTATATTTCTTCCTCGTCCCTCACAGAATCCGCT
TCGTTTTGTTTCGCCGCAGGCGCTGTAGCTTTGTGCGTCTATTCGGACGAAAGATACTAGTAT
CACGTCATTTTTGCCTCCATTCCCTCACTCTTCCCTGAGGCCTGAGGAAGCTTCGCTATTTAC
TTTCTTCTCCCGAACAAATAACCAAAAAACGAAGAAATAACTATCCTTATCATCTCGGAGAGC
TACAATTGGCAAGGGTCGCACCCTCTCGCTATGGGCTTGCTGTaaggaaatatggaaaccctg
tccccatctcaccgtgcgcatttttgttacagaacaacaaatttcttacaaccaaaaattctt
attccagAGCGCTTGGCACCCCGCTGGCCTGGCCGGAAGCAAAAAAAAGTGCACAGCAAGTCA
GAGAATGGGGGATTGAAgtaagcgcgcgcctctcctttgcacgcaaaccagccagccatgttt
taaaatgttcccgttctgcgtcgctgaacctatttcgcttagCAACTTCTGGCCATCTGGGGG
AAGGCAAAGGGAAAAGAGCGAGATGCGCTGCTCTGGGGCGATGAGGTAtggattgacctcccg
gtctatgttttgaatatatatattcaaatacatatttcttgagtgttttgctgatgaatgggt
ttgcggcgaactaggtTGAGTATCTCGTCGTAGCGGTGGATGAGAAGGCGCAGAAAGTGCGAC
TTTCACTCCACCAGGCCGAGCTCTTGAATTCGCTGGCGCAAGAGGAAGTGCAGGCAAATGGGG
AATTGGTCCAGGGGCTCCTGGATGGAGTgtatgtgattaccatcactgaattagcccgcgtct
cttcgctatattcctacgttctttgatccatatggggatttattttgttgcgttgcctctaat
ttggcctgttttggtcctacagAAAAGAACCGCTTCCCAAGTTCCATCCCGAGTTTGGGCGTT
TTATGCTGGAAGCAACACCAGGAAAGCCATGGGGGATTGGATTCCAAGACCTCTTGAGAGTCG
AGTCCAATATGAAGTGGAGGtacattacttcgtttaaacatttccatcaatgtgcttgagttc
cccacgaactgaaatgagctaaaattaaaatgttggactcgggtggataggAGAGTTATTGCG
AAAAAACATATGGCACCGAATGAATACCCCATAACCCTCACCACATTCCCACAACTAGGCACC
AAGGGTGATTTCACACAACCATTCTATCCTGTCTCGGGCAGCGCGCTCCGTTCACAGTTCGTC
CCCGACGAAATCGCAAACCCGCATATCCGTTTCCCCACACTGGCCGCAAATATTCGATGGAGG
AGAGGCAGAAAGGTGCAGCTGAACGTTCCTGTGTTTCGAGATAGGAATACCCCTTGGCCATTC
AACGACCCAACAGTCAATTACGATCTCCATAACTGGCCAGAAGACGATGATGTCCGTAATGGT
GCTGTGAAACAGAATCATGTCTATATGGATGCAATGGCGTTTGGCATGGGAAGCTGTTGTCTG
CAAATCACGTTCCAGTGTAAAAATATCAATGAGGGGAGAAGGCTCTATGACCAGCTAAGCCCC
CTGGGGCCGATAATGTTGGCTTTGACTGCCGGTACACCAATTTACAAAGGCTTCTTAGTTGAT
ACTGACGTTCGGTGGAATCAGATCAGCAAGGCAGTTGATTGCCGCACGCCTGAAGAGCTGGGA
GAGAAGgtatgcatgacattccaatctaatatagtagcgaataatctgcttttcctatgcgac
acgatcctagtactaacgaaaaatgagagtagCCGCTGAAGAATGATCGCTGGCGCATCCCAA
AGTCAAGATATGCGTCCAACTCCACATATATATCCCAAGATCCGCGACTACGACCTGAGTACA
TGGACCCAGATCTTGTCATAGACGAAGATATTAAGCAACGCCTCCTAGATGGTGGTATGGACG
ACCTGCTTGCCACGCACTTCGCCCACCTCTTCATCCGCGACCCTATCGTAGTATTTTCCGAGG
ACCTGAAGGAACTCGACCTCAACCAGACCAATCACTTCGAGAATCTGCAGTCGACAAACTGGC
AACACATCCGCTTCAAACCGCCGCCGGCCGAAAACGACATCGGCTGGCGCGTCGAGTTCCGCC
CGATGGAGATCCAGATTACCGATTTCGAAAATGCCGCTTTCAGCGTCTTCATGGTCCTCATCA
CTCGCGCCATTCTCAGTTTCGATCTAAATCTCTACATCCCCATCCCACGCACAACAATGAACA
TGGAAACCGCCCACGCACGTAATGCCGTCCTCGAGCAGAAATTCTACTTCCGCAAAGACCCCT
TTCCACACCGTATATCACGGCTTCATCAGCAGCACCAGCACCAGCACCAGCAGCAGCCCAACA
GTAACCCGAACAGCACTAGCGGTAACACATCAGATTCCAGCTCCCGCTACTCCTCCGGTTTCT
CAACGCCGAACCTACGTCCCATCGAATCCGAGTATGAGCTCATGACCATCGCAGACATCGTCA
ACGGCACGGAGGACGGGTTTCCCGGCCTAATTCCGCTGGTCGAGTCGTATCTCAACGGTGTCA
ATGTCGATGTGGAGACACGGTGTCGGCTGGCGGCGTATCTGGACTTCATCCGCCGGCGTGCGG
ATGGCACTCTGTGGACGAATGCGAAGTGGATCCGCGAGTTTGTAGCCAGACATCCGGAATATA
AGCATGACAGCGTGGTTTCGGATAAGATCTGCTTTGATCTTGTCAACGCTCTTGAGGAGGTTA
CAGAGAAGGGGGGGAAGGGTGGTAGCGTTGGGTGGGAGATGTTGAGGGGTGCTAAGGAGTGAT
ATCTCCTTCTCCTTCCCTCTCGCCCTAACGGAACCCCTCCTCATTTCTTTCCCCCCTTCCCGT
TCGTTGTTGTTTGCGTAACACTCGCGCCTTGAATCTCTCCGTTCTTTTCATTGTAGATTTTGG
TGTATGTTGCCACGCATGTCATTTCTCTATTCAATGGGTGGCAGCGTTTTTTTTTTTTTTTGC
TTGAATATTT

Figure 3. GSH1 genomic DNA sequence. Introns are shown in lower case. There are 6
introns in GSH1. Translational start and stop site are in bold and underlined.

30

MGLLALGTPLAWPEAKKSAQQVREWGIEQLLAIWGKAKGKERDALLWGDE

50

VEYLVVAVDEKAQKVRLSLHQAELLNSLAQEEVQANGELVQGLLDGVKEP 100
LPKFHPEFGRFMLEATPGKPWGIGFQDLLRVESNMKWRRVIAKKHMAPNE 150
YPITLTTFPQLGTKGDFTQPFYPVSGSALRSQFVPDEIANPHIRFPTLAA 200
NIRWRRGRKVQLNVPVFRDRNTPWPFNDPTVNYDLHNWPEDDDVRNGAVK 250
QNHVYMDAMAFGMGSCCLQITFQCKNINEGRRLYDQLSPLGPIMLALTAG 300
TPIYKGFLVDTDVRWNQISKAVDCRTPEELGEKPLKNDRWRIPKSRYASN 350
STYISQDPRLRPEYMDPDLVIDEDIKQRLLDGGMDDLLATHFAHLFIRDP 400
IVVFSEDLKELDLNQTNHFENLQSTNWQHIRFKPPPAENDIGWRVEFRPM 450
EIQITDFENAAFSVFMVLITRAILSFDLNLYIPIPRTTMNMETAHARNAV 500
LEQKFYFRKDPFPHRISRLHQQHQHQHQQQPNSNPNSTSGNTSDSSSRYS 550
SGFSTPNLRPIESEYELMTIADIVNGTEDGFPGLIPLVESYLNGVNVDVE 600
TRCRLAAYLDFIRRRADGTLWTNAKWIREFVARHPEYKHDSVVSDKICFD 650
LVNALEEVTEKGGKGGSVGWEMLRGAKE

679

Figure 4. GSH 1 putative protein sequence

Figure 5. NCBI conserved domain search of GSH1. Assigned to the glutamate
cysteine synthetase superfamily.
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Figure 6. Multiple sequence alignments of GSH1 on NCBI COBALT. 1 is
Paracoccidioides brasiliensis Pb01 XM_002794377.1 2 is Aspergillus oryzae
RIB40 XM_001727672.2 3 is Histoplasma capsulatum 184AS and 4 is Homo
sapiens AB262176.1
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Sequence Analysis of GSH2
The full length cDNA of GSH2 was 1542bp. Comparison of cDNA to genomic
DNA revealed 1 intron for the GSH2 gene as shown in Figure 7. The open reading frame
can be translated into the putative GSH2 protein with 514 amino acids as shown in
Figure 8. A domain search on the NCBI website assigned the sequence to eukaryotic
glutathione synethetase superfamily as shown in Figure 9. Multiple sequence alignments
with other dimorphic fungi such as Paracoccidioides brasiliensis, and Aspergillus oryzae
show high percentage of homology between the fungi as shown in Figure 10. When
compared to Homo sapiens, the GSH2 sequence for Histoplasma capsulatum also had
similarities and conserved regions such as the ATP binding pocket and the glutathione
binding pocket (Figure 10).
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GCTGACTTCAAAGAAAGCATTGAGATAAAGAATGCTGCTGAGAATAGTAACTAGGC
ATGGGTTGTGCCTTGTCTACCCAGCGCTTCGAAGGAGTTAGCTTGACAAGCTCTCC
AACTGGATCTATTTGACGCCAACCCAGTGAATGACGCTGGCAGCGGAATATCTGCG
ACGACTCTTTTGCCAATATGGTGAGGCGGGGGCGTTTAATTAGTTAATCAACAGCA
TTAGTAATCAGATCAATGGAGACGGCTCACTCCCAGCACATCATTCGGTGATGGTT
GGGCTAGGCGGGATCGTTGCGGGGAAGAAATACGTTAACCCACCAGCATTGAGAGA
ACAGAGACGTGGTTGACTGAATATATCAAGGGTTTTTGGTGGATGCTCGTGGACCC
CCACTGCAAGTTTTTCCGGCCGAAAGTTGACCAACAACGGAGGACGCGCATTACAT
ATCAACTTCTCTTTGGCCCTATTTATATACAAGAGTCTCTCCCCGCATTCGTTTGG
CGTTGGAAATGCAGGTGGACAGATAGAGCGCTCTCATCAATTTGTCGTTGTCAAGC
CTGTATTTCTTCCCAATGGACAATTCCGTATATGTCAATTATCCCCCACCATTAAC
CCCTGAGCAGCAAGAATACCTTCTCTCCACGGTAAAAGCATGGACTCTACATCACG
GACTCTGCGTCAAACCGTCGCTAGCCCCTATAGAGACGGAATTGGATTCCCAACGC
GCGTTAGCAACTAATGCGCCCGTCACTCTTTTCCCCAGCCTTTTCCCCAAATCTTG
CTTTGACTATGCGACAGCAATCCAGCGAGAGTACAACGAATTATATGCGAGGATAA
GCTGCGATGAAACGTGGTTGGGGAAGATTATTGAAGAgtgagctgaattgttttat
ttccgtagcacccttttttagagaaacaagtaaaatgggaaaatttctatattaag
cttccgctaccgctctccgattactgactgagacgatgtgctagACTCAAGGACGT
GGATGACTTCATCGCAAACCTCTGGAAGGTTCATCTCAGCGTACAAAGGGAAGGAT
ACGTTCAGCCACTCGCTCTAGGCCTTTTCCGATCCGATTATATCACCCATCGACCA
CCTGGCTCGGCAGAGCCATCTCTCAAACAAGTGGAATTTAACACCATCTCCTCCTC
ATTTGGGGGCCTCTCAACACTTGTCACCGCACTACACACGGATCTCTTGTCTTTAC
CTCCTGGAAATCCCATTACATATCCGCCACATCCAATCCTGAAAGACCACAAGCCC
CCACCAAATACCGCCGTTGCGACCCTAGCCAACGGTCTTGCATCGGCCCATATTGC
ATATGGCCCGTCGAAATCAGAATCCCCGCTACTGCTATGCATCCTATTTGTCGTTC
AAGCCGGGGAGCGAAACCTATTCGACCAGCTGGAATTGTCCACCCGTCTTACTGAT
TTCCACAAAATCCCCGTCTTCCGACTCACAACGACAGATATCCTGGGACTAACCTC
CATCCCCTCCTCCAACCCTGCCAGGCCATTAATATACACTCCCCCCCACGCTGTCA
CCACTACGTTCGAGGTGACAACAATTTATCTACGCGGCTTCTACGGACCGGCTGAC
TACCCAGACGACTCTGCGTGGGCTGCCCGAACGCACCTAGAGCGATCCGCGGCGAT
AAAATGCCCTTCAGTCCTCAGCCAGCTCTCTGGCAGCAAGAAAGTGCAACAAGAAC
TCGCAGACCCCCACGCAGAGACGGACCATCTGGCCCATTTCCTCCCAAAGACCCAC
GCTCAAACAATCGAGAAAATCCGCGCAACGTTCGCTCCGCAATATGACCTCTCGAC
CTCCGGTCTTGGTCGCGATCTTGCCCTCAACCCCTCAACGGCAGTTCACCACGTCT
TGAAACCGCAGCGTGAGGGAGGTGGCAACAATGTCTACCGCGATGCGATTCCGGGA
TTCCTCCGTTCCATCCCGGAGAAGGATTGGAAGGGATGGATTCTTATGGAGCTGAT
TCAGCCGCCTGATGCGGCTAAAAACATGATGCTGCGCAGTGATGGGGCAGTGCTTA
GTGGGCATGTTATTAGTGAATTAGGAATGTTTGGTACTGTCCTTTGGAGGAATAAC
GGCGAGATATTGCACAATGAGCAGGGAGGCTGGCTGTTGAGGACTAAGGGGAAAGA
AAGTGATGAAGGAGGGGTGGCGGCCGGGTTTTCGTCGTTGGATAGCCTTCTGCTTC
TTTGAATCAAACTACCCCCCGTGCATGGTAGTTGACTGAAGTGGAGGTAAGTGATA
ATAGTTTATGAATAGTTTACTGTGTCATGATGTATGTCTTATAAATTGTTGGCCGC
AATTTTTTGCCCGATATGTTTTGGCCTGGGAAACCAGATGTTAGAGGGAAATCCAT
CGTACTTAGAATTTGAGTTCGTTATTCCACACCTACAAGCTTGGGAGAGATGTCCT
TTTATAAGTAGCAAATCCGAACCAGGGCATACAAAAACTTGAGATCCAGGCCACCA
GACATTACAAAGAGTAAACGGCATTATGAGTTTGCAAAGCAAAAAAAAAAAAAAAA
AAGAAAAGAAAGAAAGA

Figure 7. GSH2 genomic DNA sequence. Intron is shown in lower case. There is one
intron in GSH2 that is 123nt. Translational start and stop site are bold and underlined .
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MDNSVYVNYPPPLTPEQQEYLLSTVKAWTLHHGLCVKPSLAPIETELDSQ 50
RALATNAPVTLFPSLFPKSCFDYATAIQREYNELYARISCDETWLGKIIE 100
ELKDVDDFIANLWKVHLSVQREGYVQPLALGLFRSDYITHRPPGSAEPSL 150
KQVEFNTISSSFGGLSTLVTALHTDLLSLPPGNPITYPPHPILKDHKPLP 200
NTAVATLANGLASAHIAYGPSKSESPLLLCILFVVQAGERNLFDQLELST 250
RLTDFHKIPVFRLTTTDILGLTSIPSSNPARPLIYTPPHAVTTTFEVTTI 300
YLRGFYGPADYPDDSAWAARTHLERSAAIKCPSVLSQLSGSKKVQQELAD 350
PHAETDHLAHFLPKTHAQTIEKIRATFAPQYDLSTSGLGRDLALNPSTAV 400
HHVLKPQREGGGNNVYRDAIPGFLRSIPEKDWKGWILMELIQPPDAAKNM 450
MLRSDGAVLSGHVISELGMFGTVLWRNNGEILHNEQGGWLLRTKGKESDE 500
GGVAAGFSSLDSLLLL

517

Figure 8. GSH2 putative protein sequence.

Figure 9. NCBI Conserved domain search of GSH2 Assigned to eukaryotic
glutathione synethetase superfamily.
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Figure 10. Multiple sequence alignments of GSH2 on NCBI COBALT. 1 is
Histoplasma capsulatum 184AS GSH2 , 2 is |XP_002797923.1| glutathione
synthetase [Paracoccidioides brasiliensis Pb01] 3 is XP_001823067.1|
glutathione synthetase [Aspergillus oryzae RIB40] 4 is NP_000169.1|
glutathione synthetase [Homo sapiens]
Gene Copy Studies of GSH1, GSH2, and CDO1 Genes
A Southern blot was prepared from Histoplasma genomic DNA cut with 6-base
recognition enzymes. The blots were probed with full length GSH1, GSH2, or CDO1
cDNA. For GSH1, restriction enzymes Bgl II, ClaI, EcorV, and PstI were used along
with an uncut control lane. The results showed the digests had one band with the
exception of BglII and PstI (Figure 11 Left Panel). There are known single cut sites for
BglII and PstI inside of the GSH1 open reading frame . For GSH2, BglII, ClaI, EcorV
were used. The results showed the digests had one band (Figure 11 Right Panel). For
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CDO1, HindIII, KpnI, StuI, SapI, and XmaI restriction enzymes were used along with
an uncut control (Figure 14). Southern blot analysis of GSH1, GSH2, and CDO1 genes,
were consistent with single copy gene band expectations for the restriction enzymes used
(Figures 11 and 14). Blast analysis using the cDNA sequence of each gene on the Broad
Institute for the Histoplasma capsulatum annotated genome also confirmed these results
with 1 hit per genome of each of the genes (Figures 12, 13, and 15).

Figure 11. Southern blot analysis of GSH1 (left panel) and GSH2 (right panel).
Each lane contains 10 µg 186AS gDNA that has been cut with the enzyme listed.
The first lane of each panel contains the 1kb ladder to use for reference.
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Figure 12. Broad Institute blast output of GSH1 186AS for gene copy number.
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Figure 13. Broad Institute blast output of GSH2 186AS for gene copy number.
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Figure 14. Southern blot analysis of CDO1. Each lane contains 10 µg186AS
gDNA that has been cut with the enzyme listed. The first lane contains the 1kb
ladder to use as reference.

Figure 15. Broad Institute blast output of CDO1 186AS for gene copy number.
The CDO1 that has been annotated on the NCBI website for Histoplasma was
used accession number AY804144.1.
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Expression Studies of GSH1, GSH2, and CDO1
RNA was extracted from four Hc strains and was analyzed by northern blotting.
Hybridization analysis indicated that GSH1 was a single band of expression that was
upregulated in the yeast morphotype of all four Hc strains (Figure 16). Hybridization
analysis indicated that GSH2 also showed a single band of expression that was
upregulated in the yeast morphotype of all four Hc strains (Figure 17).The GSH2 appears
to be different molecular weights among the different Hc strains, however it is an artifact
of gel smiling due to gel heating during electrophoresis. Northern blot analysis of CDO1
indicated an expression of two CDO transcripts, indicated by lines, in Figure 18. The
blots were stripped and reprobed with 18S rRNA as a control( bottom panel of figures
16,17,and 18). Results indicated that GSH1 and GSH2 were upregulated in the yeast,
while CDO1 was expressed in both the mold and the yeast morphotypes.

Figure 16. Northern Blot of GSH1expression in four strains of Hc cDNA.
Approximately 2µg of total RNA was separated on a denaturing agarose gel and
probed with 32P labeled GSH1. Then, the blot was stripped and probed with 32P
labeled 18S rDNA as an internal control. M, mold morphotype; Y, yeast
morphotype.
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Figure 17. Northern Blot of GSH2 expression in four strains of Hc cDNA.
Approximately 2µg of total RNA was separated on a denaturing agarose gel and
probed with 32P labeled GSH2. Then, the blot was stripped and probed with 32P
labeled 18S rDNA as an internal control. M, mold morphotype; Y, yeast
morphotype

Figure 18. Northern Blot of CDO1 expression in 4 strains of Hc. Approximately 2µg of
total RNA was separated on a denaturing agarose gel and probed with 32P labeled CDO.
Then, the blot was stripped and probed with 32P labeled 18S rDNA as an internal control.
M, mold morphotype; Y, yeast morphotype.
Real Time Quantitative PCR
The experiment type in the StratageneMx3000p real-time cycler was set as
comparative Quantitation with Calibrator. The quantity of 18s rRNA was set as the
calibrator. The software calculated the Ct (threshold cycle) difference between the target
gene and calibrator and then normalized the quantity of calibrator. The quantity of target
gene would be a relative value to the 18s RNA. The data showed below (Tables 2-7;
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Figures 19-21) came from three independent experiments with three different sets of
RNA samples from both mold and yeast forms of four Hc Strains. Tables 1 and 2 are
data obtained from RT-PCR of GSH1, and is shown graphically in Figure 19. Tables 3
and 4 are data obtained from RT-PCR of GSH2 and is shown graphically in Figure 20.
Tables 5 and 6 are data obtained from RT-PCR of CDO1 , and is shown graphically in
Figure 21.
Table 2
RT-QPCR data of GSH1.
Hc Strains

Average of dRn

Standard Deviation

184 Mold

0.000288

0.000219802

184 Yeast

0.0176

0.005991

186 Mold

0.0005283

0.0002796

186 Yeast

0.00983

0.004996

217 Mold

5.0067E-05

4.4993E-06

217 Yeast

0.000685

5.027E-05

Downs Mold

0.0000638

4.619E-05

Downs Yeast

0.003794

0.002792

Note. Each value is derived from the average of three independent experiments. dRn: relative
quantity to 18s RNA calibrator.
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Table 3
The normalization of the average dRn in GSH1
Hc Strains

Average (%)

Standard Error

184 Mold
2

3.6

100

15

2

2

56

16

0.28

0.14

41

1.5

0.38

0.26

23

16

184 Yeast
186 Mold
186 Yeast
217 Mold
217 Yeast
Downs Mold
Downs Yeast
Note. The average dRn of 184 yeast cells is set as 100%.

Figure 19. The expression level of GSH1 in RT-QPCR normalized to 18s RNA
calibrator. Error bars indicate the standard error of the mean of triplicate
experiments.
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Table 4
RT-QPCR data of GSH2
Hc Strains

Average of dRn

Standard deviation

184 Mold

0.0000438

2.52684E-05

184 Yeast

0.000151

6.9E-05

186 Mold

0.0004165

0.0002821

186 Yeast

0.005355

0.00046

217 Mold

0.00000422

4.4501E-06

217 Yeast

0.0002507

0.0001278

Downs Mold

2.745E-05

1.266E-05

Downs Yeast

0.002675

0.000148

Note. Each value is derived from the average of three independent experiments. dRn: relative
quantity to 18s RNA calibrator.

Table 5
The normalization of the average dRn in GSH2
Hc Strains
184 Mold
184 Yeast
186 Mold
186 Yeast
217 Mold
217 Yeast
Downs Mold

Average (%)

Standard Error

0.8

0.45

28

13

8

5

100

8

0.08

0.08

5

2.4

0.23

5
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Table 5 (continued).
Hc Strains

Average (%)

Standard Error
49

Downs Yeast

2

Note. The average dRn of 186 yeast cells is set as 100%.

Figure 20. The expression level of GSH2 in RT-QPCR normalized to 18s RNA
calibrator . Error bars indicate the standard error of the mean of triplicate
experiments.
Table 6
RT-QPCR data CDO1
Hc Strains

Average of dRn

Standard deviation

Standard Error

184 Mold

0.000288

0.000219802

0.523048991

184 Yeast

0.0176

0.005991

0.122726234

186 Mold

0.0005283

0.0002796

0.197096204

186 Yeast

0.00983

0.004996

0.475576324

217 Mold

5.0067E-05

4.4993E-06

0.021963494
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Table 6 (continued).
Hc Strains

Average of dRn

Standard deviation

Standard Error

217 Yeast

0.000685

5.027E-05

0.08554834

Downs Mold

0.0000638

4.619E-05

0.0515783

Downs Yeast

0.003794

0.002792

0.146118504

Note. Each value is derived from the average of three independent experiments. dRn: relative
quantity to 18s RNA calibrator.

Table 7
The normalization of the average dRn in CDO1
Hc Strains

Average (%)

Standard Error

184 Mold

43.3

5.647342

184 Yeast

86.36

1.632993

186 Mold

13.87

1.885618

186 Yeast

100

4.988877

217 Mold

2.16

0.23689

217 Yeast

8.1

0.929169

Downs Mold

12.46

0.561951

Downs Yeast

77

1.590395

Note. The average dRn of 186 yeast cells is set as 100%.

47

Figure 21. The expression level of CDO1 in RT-QPCR normalized to 18s RNA
calibrator. Error bars indicate the standard error of the mean of triplicate experiments.
Western Blot Analysis of CDO1
C-terminus and N-terminus flag tag fusion of CDO1 was placed in the pRPU1
vector and transformed by electroporation into the Downs strain of Hc. Protein was
extracted from two Downs transformants and one wildtype strain of Hc. Twenty
micrograms of protein from each sample was loaded onto a 15% polyacrylamide gel,
electrophoresed, and then blotted. Western blot analysis detected a protein size of
approximately 24kDa in the extracts of transformed cells only. This results is consistent
with the predicted CDO1 protein size with the addition of the Flag Tag (Figure 22).
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Figure 22. Western blot of CDO Flag-Tag fusion. Lane 1 is the C-terminus CDO
fusion and Lane 2 is the N-ter CDO fusion. Lane 3 is the negative control. Lane 4
is loaded with protein standard. Representative of 3 western blots with an average
molecular weight of 25.7 kDa. Standard deviation was + 2.4 kDa.
Cysteine assays
Cysteine assays measured the concentration of total intracellular cysteine in
wildtype strains of Histoplasma capsulatum. The data showed below (Figure 23) came
from three independent experiments with three different sets of samples from both mold
and yeast forms of four Hc Strains.
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Figure 23. Cysteine levels of four strains of Hc in the mold and yeast morphotypes of
each strain. Results are from 3 independent experiments. Error bars indicate the standard
error of the mean of triplicate experiments. Dark bars, mold; light bars, yeast. Strain
designations are shown below each bar.
CDO Assay
Cysteine dioxygenase assays measured the concentration of cysteine sulfinic acid
(CSA) that was formed in each reaction with crude extracts of wildtype strains of
Histoplasma capsulatum. The data showed below (Figure 24) came from three
independent experiments with three different sets of samples from both mold and yeast
forms of 4 Hc Strains. The formation of CSA was detected in both the mold and yeast of
all Hc strains. Downs Yeast showed the highest yield of CSA in comparison to all the Hc
strains and morphotypes. Hc 217B mold showed the lowest yield of CSA formation. In
comparison to all the Hc strains.
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Figure 24. Assay of CDO activity in four strains of Hc in both the mold and yeast
morphotypes. Results are from 3 independent experiments Error bars indicate the
standard error of the mean of triplicate measurements. Dark bars, mold; light bars,
yeast. Strain designations are shown below each bar.
Construction of the GSH1 and GSH2 Overexpression Plasmids
Copies of GSH1 and GSH2 were amplified from Hc genomic DNA via PCR. The
PCR products were then cloned into pGEMt-easy or pCR-TOPO 2.1. The genes were
subcloned into the Hc telomeric vector pRPUT1 downstream of the strong Hc TEF1
promoter. The resulting construct contained the GSH1 or GSH2 gene driven by the TEF1
promoter, Hc telomeric repeats and the Aspergillus nidulans Ura5 gene.
Transformation of Yeast Cells With Over-Expression Plasmid
The overexpression plasmids were linearized by Pac I to remove the Tet marker
and expose the telomeric repeats. The linear plasmids were then used to transform
Hc186ura- yeast cells by electroporation. The cells were then plated on HMM to select
for URA+ transformants. PCR was used to check the transformants for the
overexpression vector. The transformants were then shifted to the mold temperature
(25°C) to see effects of overexpression on the dimorphism of the organism.
Expression Studies of GSH1 and GSH2 Overexpressing Transformants
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RNA was extracted from two GSH1 transformants and two GSH2 transformants.
Hybridization analysis indicated that GSH1 and GSH2 overexpressing mold cell
transformants had levels of expression comparable to the wildtype yeast (Figure 25).

Figure 25. Northern Blot of GSH1and GSH2 expression in wildtype and
overexpression transformants. 10 µg of RNA was loaded in each lane. T1 and T2
are GSH1 transformants and T3 and T4 are GSH2 transformants
Phenotypic Analysis of GSH1 and GSH2 Overexpressing Transformants
The yeast morphotype of the overexpressing transformants grew normally at
37°C. No difference was noted in the growth rate or the microscopic morphology when
compared to the 186AS Ura- wildtype strain or the pRPUT1 control transformant. A
resistance to change morphotypes was seen in the transformants when the temperature
was shifted from 37°C to 25°C. The wildtype strain and the control transformants both
changed to the mold morphotype, but the overexpressing transformants did not.
Microsopic analysis is shown in Figure 27. Growth analysis on HMM plates is shown in
Figure 26. The plate analysis clearly shows the wildtype shifts to mold at 25°C, while
the GSH1 and GSH2 overexpressing transformants maintain the yeast morphotype. The
vector control also shifts to mold during the 6 day incubation period. The microscopic

52
analysis along with the plate results indicate that both GSH1 and GSH2 play a role in the
dimorphism of Histoplasma capsulatum.

Figure 26. Images of Plated 186AS URA- wildtype and Overexpressing transformants
50uL inocula of 186AS Ura- yeast cells, overexpressing transformants, and the vector
control were plated on HMM then grown at 25°C for six days. The top row is GSH1
overexpressing transformants and the bottom row is GSH2 overexpressing transformants.
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186 Ura-

Lane 1

GSH 1

Lane 2

GSH 2

Lane 3

pRPUT1

Lane 4

Figure 27. Microscopic images taken at different time points after the 186AS Urawildtype in lane 1, GSH1 overexpressing transformant in lane 2, GSH2
overexpressing transformant in lane 3, and a pRPUT1 vector control in lane 4
yeast were shifted to 25°C. The top row is at 0 hours, the second row is at 42
hours, the third row is at 96 hours, and the bottom row is 120 hours.
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CHAPTER V
DISCUSSION
Sequence Analysis of GSH1 and GSH2
The GSH1 gene has 6 introns and is 2037 nucleotides and encodes a protein 679
amino acids in length as shown in Figures 3 and 4. The GSH2 gene is 1548 nucleotides
in length and has one intron of 123 nucleotides as shown in Figures 7 and 8. The
presence of introns and the determination of intron/exon boundaries were based on
several RACE PCRs. Independent sequencing results shows a sequence match with
186AS from the Hc 186AS genome database at Washington University Genome
Sequencing Center and the Broad Institute.
High similarities were found between the respective GSH1 sequences of many
fungi from the same phylum as Histoplasma capsulatum. The BLASTx search of the Hc
GSH1 indicated a 81% identity and an 89% similarity with GSH1 from Paracocidiodes
brasiliensis strain Pb01. (NCBI Accession no. XM_002794377.1) and a 57% identity
and a 73% similarity with GSH1 from Aspergillus oryzae RIB40 (NCBI accession no.
XM_001727672.2) (Figure 6). The BLASTx search also indicated a 97% similarity with
Ajellomyces capsulatus NAm1 glutamate--cysteine ligase (HCAG_01120) partial mRNA
(NCBI accession no. XM_001544024.1). A domain search also indicated that it was part
of the eukaryotic glutamate cysteine synthetase super family (Figure 5).
Similar comparisons with Hc GSH2 indicated a 80% identity and a 87%
similarity with Paracoccidiodes brasiliensis strain Pb03 and a 67% identity and a 86%
similarity to Asperigillus fumigatus strain Af293. The protein sequences of these
homologs for Hc, Pb, and Af all have 526 amino acids. When compared with Homo
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sapiens¸ the amino acid sequence is shorter with only 474 amino acids.(Figure 10). A
domain search on the NCBI site revealed many conserved domains for GSH2. These
domains include an ATP: binding sites and a glutathione binding pocket. The domain
search also indicated GSH2 belongs to the eukaryotic glutathione sythetase superfamily
(Figure 9).
The Genomic Copy Number of GSH1, GSH2, and CDO1
Southern blots were prepared from Histoplasma genomic DNA cut with various
6-base restriction enzymes. The blots were then probed with full length GSH1, GSH2, or
CDO1 cDNA. The results were consistent with single copy genes (Figures 11 and 14).
In Figure 11, the PstI and BglII lanes have two bands instead of one. There are known
BglII and PstI cute sites inside of the GSH1 open reading frame, which after digestion
leaves 2 fragments of the open reading frame as seen in the figure. In Figure 14, the SapI
and XmaI lanes did not have a band, this could be due to the enzymes not effectively
cutting the DNA. In the gel before blotting, it appeared as though those lanes were still
high molecular weight DNA suggesting incomplete digestion. Blast searches with the
gene sequences on the Broad institute also indicated single copy genes. GSH1 had 3 hits
on the 186 AR genome (Figure 12). However only one of them was the whole sequence.
The other two hits were just very short sequence hits of the same DNA sequence. Both
GSH2 and CDO1 had only one hit on the 186 AR genome (Figures 13 and 15). These
results were in agreement with the southern blot data. It has also been reported that these
genes are single copy or very low copy in other organisms such as Plasmodium berghei,
the haploid human genome, and Arabidopsis thaliana (3, 38, 19).
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The Expression Level of GSH1, GSH2, and CDO1
The transcription level of GSH1 and GSH2 were relatively low in the mold
morphotype as revealed by both northern blot analysis and the real-time PCR analysis
(Figures 16, 17, 19 and 20). There was only a weak signal detected in the mold
morphotype on northern blots of total RNA as shown in Figure . The mRNA level for
GSH1, GSH2, and CDO1 was the lowest in the 217B strain. The expression level was
decreased as much as 20 fold in between the strains. The GSH2 appears to be different
molecular weights among the different Hc strains, however it is an artifact of gel
“smiling” due to gel heating during electrophoresis. The RT-PCR data from four Hc
strains, likewise indicated that strain G217B had the lowest overall expression of CDO of
the four strains examined in this study (Figures 18 and 21).
GSH1 and GSH2 Are More Abundant in Yeast Cells
From the northern blot analysis, the genes are upregulated in the yeast phase of
the organism. In 186AS, GSH1 has a striking 12 fold increase in expression in the yeast
phase (Figure 19) which is consistent with other dimorphic fungi such as Candida
albicans and Penicillium chrysogenum that are affected by the concentrations of
glutathione (34, 25). In Candida albicans, a 100 fold decrease in glutathione is required
for the yeast to mold dimorphism (34). In Penicillium chrysogenum, a high intracellular
glutathione level is favored in the yeast morphotype (25). This also is supported by the
shotgun microarray that was done for Hc (12) which showed several genes that were
upregulated in the yeast and were involved in sulfur metabolism. GSH2 is also expressed
more strongly in the yeast. In 186AS, the expression level increased 28 fold in the yeast
morphotype (Figure 20).
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CDO1 Expression Analysis
Northern blot analysis indicated that the Hc CDO1 gene is expressed as two
discrete transcripts. The transcripts are approximately 1600 and 1350 nucleotides in size
(Figure 18). This has been seen in other organisms as well, multiple studies in mice and
humans have seen more than one transcript. The formation of thioether crosslinks cause
changes in the size of the protein product. (32). The higher molecular weight transcript is
thought to produce the more active enzyme due to the blocking of the –SH group from
the formation of a thioether crosslink in the active site (32). There is expression in both
the mold and the yeast phases in all 4 strains of Hc. In 184AS there is a 2X change in
expression from the mold to the yeast. The abundance of CDO mRNA seen in the
Northern blot analysis was an interesting result. Kumar’s earlier studies suggested that
CDO activity was yeast specific(18). It was interesting that the northern blot analysis
(Figure 18) clearly indicates some expression of CDO1 in the mold morphotype
especially in 184AS.The unexpected expression of CDO1 in the mold prompted the
CDO1 activity assays in order to see if activity was really yeast specific. The highest
expression level is in the yeast morphotype of Downs and 186AS strains. Both strains
have a six fold expression increase in the yeast phase. This large expression increase
seen in the RT-PCR data may be due to the measurement of both transcripts that are seen
in the northern blot analysis.
CDO1 Protein Size Determination
Western blot analysis revealed a protein of ~25.7kDa in size. The FLAG TAG
added 2.02 kDa, when subtracted from the 25.7kDa protein seen in the western blot,
gives an overall size for the CDO protein of 23.7 kDa (Figure 22). The finding is
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consistent with CDO genes in other organisms as shown in Table 8. Our results are in
contrast to Kumar et al. who reported a protein size of 10.5 kDa. Discrepancies in
Kumar’s data and our data could be a result of Kumar measuring proteolyticly degraded
fragments.
Table 8
Shows various known CDO protein sizes in different organisms.
Organism

CDO protein size in kDa

NCBI reference number

Homo sapiens

22.9

NM001801

Mus musculus

27.6

NP611348

Drosphilia Melanogaster

23

BAA11925

Histoplasma capsulatum

23.7

AY804144

CDO1 Activity
Kumar et al. reported CDO1 enzyme activity was yeast specific in the Downs
strain of Hc (18). The study used an O2 electrode in order to measure the amount of
oxygen consumed when cysteine was added to cell extracts. Instead of measuring oxygen
consumption, the CDO assays performed in this study directly measured the product of
CDO1, cysteine sulfinic acid. The CDO assays showed that there is some activity in the
mold morphotypes of all strains, but particularly in 184AS the level of activity is close to
the same as that for the yeast. Figure 24 shows mRNA expression and enzyme activity in
both forms; however, expression was higher in the yeast morphotype. Results indicated
that Downs yeast had the most CDO activity. From the expression analysis results in
Figure 18, the 186AS appears to have the greatest expression of CDO1 on average about
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25% more than the other strains. These results can be explained by the two transcripts
that are seen in the northern blot analysis (Figure 18). In other organisms, the larger
transcript is the more catalytically active one. For example, greatest CDO activity was
seen in the yeast morphotype of the Downs strain. This strain also appears to have the
greatest expression of the larger transcript (Figure 18). Thus we see a strong correlation
of the abundance of the large CDO transcript with measured CDO enzyme activity.
Intracellular Cysteine Concentrations
Cysteine assays indicated that there is a steady amount of cysteine in both the
mold and yeast phases of the organism (Figure 23). The 184 AS mold morphotype has
the most abundant intracellular cysteine while the 217B mold has the least. Overall, the
mold and yeast did not see large differences in cysteine concentrations between the mold
and yeast morphotypes.
Phenotypic Analysis of GSH1 and GSH2 Overexpressing Transformants
Overexpression of GSH1 and GSH2, inhibited the transition of yeast to mold at
25ºC. The increase in glutathione production may increase the redox potential of the cell
to a level which signals the cell to remain in the yeast morphotype despite the
temperature reduction. As shown in Figures 25, 26, and 27, cells overexpressing GSH1
remained in the yeast form even after the shift to 25° C. However, cells overexpressing
GSH2 remained primarily in the yeast form but did begin to make germ tubes as well as
very short hyphae. This could be due to GSH1 being the primary rate limiting step - thus,
cells overexpressing GSH2 still have normal (rate limiting) amounts of GSH1 and exhibit
a more normal (i.e., hyphae formation at 25° C) phenotype. FUN1 cell viability stains
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showed the GSH1 and GSH2 overexpression transformants are alive at least up to 12 days
after the shift to 25°C. At day 14, about 80% of the transformants were dead.
Model of Cysteine Metabolism and Dimorphism
There are two pathways in which cysteine can be utilized in the cell (Figure 28).
One is a degradative pathway where the -SH group (from cysteine) is lost and converted
ultimately to sulfite. The degradative pathway is controlled by the irreversible breakdown
of cysteine to cysteine sulfinic acid. The CDO1 gene is present and active in both the
mold and yeast morphotypes. Studies in our lab found SH degrading genes, AAT and
SOX, also are expressed in both the mold and yeast morphotypes of the four Hc strains.
The other pathway is the conversion of cysteine into glutathione. In this pathway, the -SH
group is protected and the reducing ability is still available to the cell. Perhaps
upregulation of GSH1 and GSH2 in the yeast morphotype is needed to maintain sufficient
free -SH groups (and hence a more reducing cytoplasmic microenvironment) needed to
form and maintain the single-celled yeast form of the organism. This “extra” -SH may
also help protect the cell from oxidative stress resulting from an increase in temperature
or other environmental assault. This could explain the inability to knockout these genes
in Histoplasma (22). A knockout of GSH1 or GSH2 could be lethal to the cell.
Overexpression of GSH1 and GSH2 resulted in the inability of the organism to shift to
the mold state which indicates that the glutathione biosynthetic genes may play a role in
regulating the sulfhydryl groups in the cell. A change in the sulfhdryl concentration may
indicate that the organism needs to switch morophotypes. Due to the upregulation in the
yeast phase, results indicate that extra sulfhydryl groups signal the cell to stay in the yeast
morphotype. The results have been seen in other dimorphic organisms as well. Reduction
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oxidation potential plays a large role in signaling the cell to stay in the mold morphotype,
if there is a high redox potential. If there is a low redox potential, the signal favors the
yeast phase Glutathione in the cell lowers the redox potential sending a signal that favors
the yeast morphotype (35).

Figure 28. Example of proposed model of cysteine metabolism and dimorphism.
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APPENDIX
GSH1 PRIMERS USED IN RACE PCR
Primer Name

Primer Sequence

GSH1 F3

GAGAGTAGCCGCTGAAGAATG

GSH1 R3

CGACTCGACCAGCGGAATTAG

GSH1 F4

GCACCGAATGAATACCCCATAACC

GSH1 R4

CTGATTCCACCGAACGTCAGTATC

GSH1 RACE PCR NES F

CTCGCGGATCCACTTCGCATT

GSH1 RACE PCR NES R

CGACCTGCTTGCCACGCACTT

GSH1 F1 11-28N

TCACCACATTCCCACAACTAG

GSH1 R1 11-28N

GCTACAAACTCGCGGATCCAC

GSH2 PRIMERS USED IN RACE PCR
Primer Name

Primer Sequence

GSH2 F N

GGGCAAGATCGCGACCAAGAC

GSH2 R N

CGAAGGAGTTAGCTTGAC

F2 5T2

GAGCGAGTGGCTGAACGTATC

R2 5T2

CCGGCCGAAAGTTGACCAACA

GSH2 RACE PCR NES F

TCCATGCTTTTACCGTGGAGA

GSH2 RACE PCR NES R

GGATATCAGTTTTATATCGGC

GSH2 F5 11-28N

ACAGCCAGCCTCCCTGCTCAT

GSH2 B23 11-28N

TTCATCTCAGAGTACAAAGGG
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PRIMERS USED FOR SOUTHERN BLOT PROBES
PRIMER NAME

PRIMER SEQUENCE

SB CDO1 F

AACGAGAGCGAATGGGAACG

SB CDO1 R

TTTAGGACGGAAAGGAGCATCC

SB GSH1 F

CGATGATGTCCGTAATGGTGC

SB GSH1 R

TGGGATGGGGATGTAGAGATTTAG

SB GSH2 F

ACTCTACATCACGGACTCTGCGTC

SB GSH2 R

GAGGACTGAAGGGCATTTTATCG
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